Latest Options News

Mount Burgess Mining NL has secured agreements to extinguish nearly $4.7 million in legacy debt, converting a small portion into equity and options, positioning the company for renewed growth.

Multistack International has announced the discontinuation of its current business operations following a significant asset sale that settled a $3.55 million loan, signaling a major strategic shift for the company.

Aldoro Resources has confirmed a major expansion of its Kameelburg polymetallic deposit in Namibia, doubling the mineralisation footprint and enhancing drilling capabilities to deepen resource definition.

Supply Network Limited has announced a fully franked ordinary dividend of AUD 0.38 per share for the fiscal year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 2.5% discount on new shares.

Aeris Resources has outlined a robust FY26 plan focusing on increased copper equivalent production and strategic asset management, aiming to enhance shareholder value through operational delivery and exploration.

H&S Group has exercised performance options to increase its stake in Nuchev Limited to 48.62%, injecting $1.9 million and enhancing Nuchev’s financial flexibility for growth.

Askari Metals supplements its Nejo Gold Project acquisition announcement with detailed drill hole data and confirms the reliability of historical exploration results, while noting compliance limitations.

Kingfisher Mining has secured a strategic portfolio of copper, gold, silver, lead, and zinc projects across New South Wales, backed by a $1.85 million capital raise to accelerate exploration.

New World Resources Limited has formally recommended shareholders accept Kinterra Capital's unconditional $0.067 per share takeover offer, following the withdrawal of a competing bid. The offer represents a substantial premium over recent trading prices and includes provisions for option cancellations and accelerated vesting of performance rights.

Leo Lithium has received the final US$177.6 million payment from Ganfeng for its Goulamina stake and is advancing multiple lithium hard rock acquisitions, aiming to relist on the ASX.

Vanadium Resources Limited has raised A$1.2 million through an oversubscribed placement to support its near-term production ambitions and convert outstanding debt into equity, strengthening its balance sheet.

Neurizon Therapeutics has formally responded to the FDA's clinical hold on its lead ALS drug NUZ-001, submitting new animal safety data. The company aims to join the HEALEY ALS Platform Trial by late 2025, pending regulatory approval.